-
Latest Annual Report
( FY 2018 )Latest Annual Report 1.5 MB -
Sarepta Therapeutics 2019 J.P. Morgan Healthcare Conference Presentation
SEC Filings
| Filing date | Form | Description | Filing Group | View |
|---|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Proxy Filings
|
View HTML | |
| DEFA14A | Additional proxy soliciting materials - definitive |
Proxy Filings
|
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML |
Displaying 1 - 10 of 1046 results
Copyright Morningstar
-
Latest Annual Report
( FY 2018 )Latest Annual Report 1.5 MB -
Sarepta Therapeutics 2019 J.P. Morgan Healthcare Conference Presentation